Enzymatica and STADA Reunited – Featured in BioStock
A new article from BioStock highlights Enzymatica’s recently announced partnership with STADA Arzneimittel AG for the launch and distribution of ColdZyme technology in Germany and Austria.
The article covers:
- The background of the renewed partnership
- Opportunities in the German and Austrian markets
- The expected commercial development ahead
- What the collaboration means for Enzymatica’s growth strategy
The partnership marks an important step in Enzymatica’s international expansion and further strengthens the company’s position within the cold and respiratory category.